93 related articles for article (PubMed ID: 29325795)
1. Insertional Mutagenesis Confounds the Mechanism of the Morbid Phenotype of a PLN
Kraev A
J Card Fail; 2018 Feb; 24(2):115-125. PubMed ID: 29325795
[TBL] [Abstract][Full Text] [Related]
2. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
Schmitt JP; Ahmad F; Lorenz K; Hein L; Schulz S; Asahi M; Maclennan DH; Seidman CE; Seidman JG; Lohse MJ
Circulation; 2009 Jan; 119(3):436-44. PubMed ID: 19139388
[TBL] [Abstract][Full Text] [Related]
3. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ
J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948
[TBL] [Abstract][Full Text] [Related]
4. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model.
Kaneda T; Naruse C; Kawashima A; Fujino N; Oshima T; Namura M; Nunoda S; Mori S; Konno T; Ino H; Yamagishi M; Asano M
Clin Sci (Lond); 2008 Mar; 114(6):431-40. PubMed ID: 17956225
[TBL] [Abstract][Full Text] [Related]
5. Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy.
Kuzmanov U; Guo H; Buchsbaum D; Cosme J; Abbasi C; Isserlin R; Sharma P; Gramolini AO; Emili A
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12592-12597. PubMed ID: 27742792
[TBL] [Abstract][Full Text] [Related]
6. Early calcium and cardiac contraction defects in a model of phospholamban R9C mutation in zebrafish.
Vicente M; Salgado-Almario J; Valiente-Gabioud AA; Collins MM; Vincent P; Domingo B; Llopis J
J Mol Cell Cardiol; 2022 Dec; 173():127-140. PubMed ID: 36273660
[TBL] [Abstract][Full Text] [Related]
7. Cardiac-Specific Cre Induces Age-Dependent Dilated Cardiomyopathy (DCM) in Mice.
Rehmani T; Salih M; Tuana BS
Molecules; 2019 Mar; 24(6):. PubMed ID: 30917606
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses.
Gramolini AO; Kislinger T; Alikhani-Koopaei R; Fong V; Thompson NJ; Isserlin R; Sharma P; Oudit GY; Trivieri MG; Fagan A; Kannan A; Higgins DG; Huedig H; Hess G; Arab S; Seidman JG; Seidman CE; Frey B; Perry M; Backx PH; Liu PP; MacLennan DH; Emili A
Mol Cell Proteomics; 2008 Mar; 7(3):519-33. PubMed ID: 18056057
[TBL] [Abstract][Full Text] [Related]
9. Cardiac expression of Gal4 causes cardiomyopathy in a dose-dependent manner.
Habets PE; Clout DE; Lekanne Deprez RH; van Roon MA; Moorman AF; Christoffels VM
J Muscle Res Cell Motil; 2003; 24(2-3):205-9. PubMed ID: 14609031
[TBL] [Abstract][Full Text] [Related]
10. Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related Cardiomyopathy.
Eijgenraam TR; Boogerd CJ; Stege NM; Oliveira Nunes Teixeira V; Dokter MM; Schmidt LE; Yin X; Theofilatos K; Mayr M; van der Meer P; van Rooij E; van der Velden J; Silljé HHW; de Boer RA
Circ Heart Fail; 2021 Nov; 14(11):e008532. PubMed ID: 34587756
[TBL] [Abstract][Full Text] [Related]
11. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing.
Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H
Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280
[TBL] [Abstract][Full Text] [Related]
12. Mitigation of Stress-induced Structural Remodeling and Functional Deficiency in iPSC-CMs with PLN R9C Mutation by Promoting Autophagy.
Yu Q; Barndt RJ; Shen Y; Sallam K; Tang Y; Chan SY; Wu JC; Liu Q; Wu H
bioRxiv; 2024 Apr; ():. PubMed ID: 38659742
[TBL] [Abstract][Full Text] [Related]
13. Altered myocyte contractility and calcium homeostasis in alpha-myosin heavy chain point mutations linked to familial dilated cardiomyopathy.
Klos M; Mundada L; Banerjee I; Morgenstern S; Myers S; Leone M; Kleid M; Herron T; Devaney E
Arch Biochem Biophys; 2017 Feb; 615():53-60. PubMed ID: 28088328
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Polycomb-group gene rae28 in cardiomyocytes does not complement abnormal cardiac morphogenesis in mice lacking rae28 but causes dilated cardiomyopathy.
Koga H; Kaji Y; Nishii K; Shirai M; Tomotsune D; Osugi T; Sawada A; Kim JY; Hara J; Miwa T; Yamauchi-Takihara K; Shibata Y; Takihara Y
Lab Invest; 2002 Apr; 82(4):375-85. PubMed ID: 11950896
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies.
Fish M; Shaboodien G; Kraus S; Sliwa K; Seidman CE; Burke MA; Crotti L; Schwartz PJ; Mayosi BM
Sci Rep; 2016 Feb; 6():22235. PubMed ID: 26917049
[TBL] [Abstract][Full Text] [Related]
16. Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period.
Cannon L; Yu ZY; Marciniec T; Waardenberg AJ; Iismaa SE; Nikolova-Krstevski V; Neist E; Ohanian M; Qiu MR; Rainer S; Harvey RP; Feneley MP; Graham RM; Fatkin D
J Am Coll Cardiol; 2015 Feb; 65(6):560-9. PubMed ID: 25677315
[TBL] [Abstract][Full Text] [Related]
17. Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype.
Abraham WT; Gilbert EM; Lowes BD; Minobe WA; Larrabee P; Roden RL; Dutcher D; Sederberg J; Lindenfeld JA; Wolfel EE; Shakar SF; Ferguson D; Volkman K; Linseman JV; Quaife RA; Robertson AD; Bristow MR
Mol Med; 2002 Nov; 8(11):750-60. PubMed ID: 12520092
[TBL] [Abstract][Full Text] [Related]
18. Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice.
Colbert MC; Hall DG; Kimball TR; Witt SA; Lorenz JN; Kirby ML; Hewett TE; Klevitsky R; Robbins J
J Clin Invest; 1997 Oct; 100(8):1958-68. PubMed ID: 9329959
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice.
Lu D; Ma Y; Zhang W; Bao D; Dong W; Lian H; Huang L; Zhang L
Hypertension; 2012 Jul; 60(1):81-9. PubMed ID: 22665122
[TBL] [Abstract][Full Text] [Related]
20. Cardiac-specific and ligand-inducible target gene expression in transgenic mice.
Bo J; Yu W; Zhang YM; Demayo FJ; Wei L
J Mol Cell Cardiol; 2005 Apr; 38(4):685-91. PubMed ID: 15808845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
